首页 > 最新文献

Hematologie最新文献

英文 中文
Association du rituximab et du vémurafénib en traitement de la leucémie à tricholeucocytes 利妥昔单抗和vemurafenib联合治疗毛细白细胞白血病
Q4 HEMATOLOGY Pub Date : 2021-10-01 DOI: 10.1684/hma.2021.1692
N. Stocker
{"title":"Association du rituximab et du vémurafénib en traitement de la leucémie à tricholeucocytes","authors":"N. Stocker","doi":"10.1684/hma.2021.1692","DOIUrl":"https://doi.org/10.1684/hma.2021.1692","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46217474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SFH 2021 2021年SFH
Q4 HEMATOLOGY Pub Date : 2021-08-01 DOI: 10.1684/hma.2021.1656
{"title":"SFH 2021","authors":"","doi":"10.1684/hma.2021.1656","DOIUrl":"https://doi.org/10.1684/hma.2021.1656","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47381407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
News in thrombotic thrombocytopenic purpura and ADAMTS13 血栓性血小板减少性紫癜和ADAMTS13的最新进展
Q4 HEMATOLOGY Pub Date : 2021-08-01 DOI: 10.1684/hma.2021.1655
B. Joly, Nicolas Béranger, Y. Benhamou, P. Coppo, A. Veyradier
{"title":"News in thrombotic thrombocytopenic purpura and ADAMTS13","authors":"B. Joly, Nicolas Béranger, Y. Benhamou, P. Coppo, A. Veyradier","doi":"10.1684/hma.2021.1655","DOIUrl":"https://doi.org/10.1684/hma.2021.1655","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67566732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neutrophil extracellular traps: key drivers of severe Covid-19 中性粒细胞细胞外陷阱:严重Covid-19的关键驱动因素
Q4 HEMATOLOGY Pub Date : 2021-07-01 DOI: 10.1684/hma.2021.1682
Cécile Oury, Thomas Marichal
In severe Covid-19, hyperinflammatory tissue-damaging, thromboembolic or immunothrombotic responses triggered by Sars-Cov-2 are major causes of respiratory failure and death. Neutrophil extracellular traps (NETS), released by activated neutrophils during a process called NETosis, can be formed in the lungs upon infection with respiratory viruses. They have the ability to promote lung damage, thrombosis and fibrosis, three cardinal features encountered in severe Covid-19. In a recent study, we sought to understand how NETosis could relate to lung immunopathological changes associated with fatal cases of the disease. We assessed whether NET structures could be identified in post-mortem lung biopsies from Covid-19 patients, and whether they were located in particular lesions and micro-anatomical lung compartments. We performed immunofluorescence staining of myeloperoxi-dase, citrullinated histone H3 and nuclear acid (DAPI) on sections of paraffin-embedded lung biopsies from four Covid-19 patients who succumbed Covid-19 and from four patients who died from a Covid-19-unrelated cause. The four patients represented prototypical severe and fatal cases of Covid-19, characterized by pneumonia and fatal respiratory distress associated with signs of systemic inflammation, neutrophilia and coagulopathy. NETs were uniquely detected in the lungs of each Covid-19 patient. Detailed histopathological analysis revealed widely distributed NET-infiltrating areas encompassing several lung compartments, including arteriolar microthrombi, neutrophil-rich inflammatory areas of lung interstitium as well as alveoli or bronchioles where they often co-localized with occluding fibrin-rich deposits. Another study published simultaneously to ours provides first experimental evidence for causality between NETosis and lung injury in severe Covid-19. However, the possible involvement of NETs in thrombogenesis remains to be addressed. Notwithstanding, these data support the hypothesis that NETs may represent drivers of Covid-19-associated severe pulmonary complications, and suggest that NET-targeting approaches could represent potential avenues for the treatment of uncontrolled tissue-damaging, thrombotic or fibrotic responses to Sars-Cov-2.
在重症Covid-19中,由Sars-Cov-2引发的高炎症性组织损伤、血栓栓塞或免疫血栓反应是呼吸衰竭和死亡的主要原因。中性粒细胞胞外陷阱(NETS)是由活化的中性粒细胞在NETosis过程中释放的,感染呼吸道病毒后可在肺部形成。它们能够促进肺损伤、血栓形成和纤维化,这是重症Covid-19的三个主要特征。在最近的一项研究中,我们试图了解NETosis如何与致命病例相关的肺免疫病理变化有关。我们评估了是否可以在Covid-19患者的死后肺活检中发现NET结构,以及它们是否位于特定病变和微解剖肺室中。我们对4名死于Covid-19的Covid-19患者和4名死于Covid-19无关原因的患者的石蜡包埋肺活检切片进行了髓过氧化物酶、瓜氨酸化组蛋白H3和核酸(DAPI)的免疫荧光染色。这4例患者是典型的Covid-19重症和致命性病例,其特征是肺炎和致命性呼吸窘迫,并伴有全身性炎症、嗜中性粒细胞和凝血功能障碍。net在每个Covid-19患者的肺部被独特地检测到。详细的组织病理学分析显示广泛分布的net浸润区包括几个肺室,包括小动脉微血栓,肺间质富含中性粒细胞的炎症区以及肺泡或细支气管,它们通常与闭塞的富含纤维蛋白的沉积物共定位。与我们同时发表的另一项研究为NETosis与严重Covid-19肺损伤之间的因果关系提供了第一个实验证据。然而,NETs在血栓形成中的可能参与仍有待解决。尽管如此,这些数据支持NETs可能代表covid -19相关严重肺部并发症驱动因素的假设,并表明靶向net的方法可能代表治疗对Sars-Cov-2不受控制的组织损伤、血栓形成或纤维化反应的潜在途径。
{"title":"Neutrophil extracellular traps: key drivers of severe Covid-19","authors":"Cécile Oury, Thomas Marichal","doi":"10.1684/hma.2021.1682","DOIUrl":"https://doi.org/10.1684/hma.2021.1682","url":null,"abstract":"In severe Covid-19, hyperinflammatory tissue-damaging, thromboembolic or immunothrombotic responses triggered by Sars-Cov-2 are major causes of respiratory failure and death. Neutrophil extracellular traps (NETS), released by activated neutrophils during a process called NETosis, can be formed in the lungs upon infection with respiratory viruses. They have the ability to promote lung damage, thrombosis and fibrosis, three cardinal features encountered in severe Covid-19. In a recent study, we sought to understand how NETosis could relate to lung immunopathological changes associated with fatal cases of the disease. We assessed whether NET structures could be identified in post-mortem lung biopsies from Covid-19 patients, and whether they were located in particular lesions and micro-anatomical lung compartments. We performed immunofluorescence staining of myeloperoxi-dase, citrullinated histone H3 and nuclear acid (DAPI) on sections of paraffin-embedded lung biopsies from four Covid-19 patients who succumbed Covid-19 and from four patients who died from a Covid-19-unrelated cause. The four patients represented prototypical severe and fatal cases of Covid-19, characterized by pneumonia and fatal respiratory distress associated with signs of systemic inflammation, neutrophilia and coagulopathy. NETs were uniquely detected in the lungs of each Covid-19 patient. Detailed histopathological analysis revealed widely distributed NET-infiltrating areas encompassing several lung compartments, including arteriolar microthrombi, neutrophil-rich inflammatory areas of lung interstitium as well as alveoli or bronchioles where they often co-localized with occluding fibrin-rich deposits. Another study published simultaneously to ours provides first experimental evidence for causality between NETosis and lung injury in severe Covid-19. However, the possible involvement of NETs in thrombogenesis remains to be addressed. Notwithstanding, these data support the hypothesis that NETs may represent drivers of Covid-19-associated severe pulmonary complications, and suggest that NET-targeting approaches could represent potential avenues for the treatment of uncontrolled tissue-damaging, thrombotic or fibrotic responses to Sars-Cov-2.","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44965034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Sickle cell disease and risk of haematological malignancies 镰状细胞病和血液恶性肿瘤的风险
Q4 HEMATOLOGY Pub Date : 2021-07-01 DOI: 10.1684/hma.2021.1660
F. Bernaudin, M. Kuentz, Y. Beuzard
{"title":"Sickle cell disease and risk of haematological malignancies","authors":"F. Bernaudin, M. Kuentz, Y. Beuzard","doi":"10.1684/hma.2021.1660","DOIUrl":"https://doi.org/10.1684/hma.2021.1660","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41658840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New therapeutic options for older unfit AML patients (excluding targeted therapies) 老年不适合AML患者的新治疗选择(不包括靶向治疗)
Q4 HEMATOLOGY Pub Date : 2021-03-01 DOI: 10.1684/HMA.2021.1631
M. Cerrano, R. Itzykson
{"title":"New therapeutic options for older unfit AML patients (excluding targeted therapies)","authors":"M. Cerrano, R. Itzykson","doi":"10.1684/HMA.2021.1631","DOIUrl":"https://doi.org/10.1684/HMA.2021.1631","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49469932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’interféron pour tout patient présentant une polyglobulie de Vaquez ? 干扰素对Vaquez多球症患者有效吗?
Q4 HEMATOLOGY Pub Date : 2021-03-01 DOI: 10.1684/HMA.2021.1643
Laura Cailly, Émilie Cayssials, J. Torregrosa-Diaz
{"title":"L’interféron pour tout patient présentant une polyglobulie de Vaquez ?","authors":"Laura Cailly, Émilie Cayssials, J. Torregrosa-Diaz","doi":"10.1684/HMA.2021.1643","DOIUrl":"https://doi.org/10.1684/HMA.2021.1643","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43184737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Éditorial 社论
Q4 HEMATOLOGY Pub Date : 2020-12-01 DOI: 10.1684/hma.2020.1610
M. Mohty
{"title":"Éditorial","authors":"M. Mohty","doi":"10.1684/hma.2020.1610","DOIUrl":"https://doi.org/10.1684/hma.2020.1610","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46495557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New drugs toxicity: incidence and management 新药毒性:发生率和管理
Q4 HEMATOLOGY Pub Date : 2020-12-01 DOI: 10.1684/hma.2020.1608
D. Sibon
{"title":"New drugs toxicity: incidence and management","authors":"D. Sibon","doi":"10.1684/hma.2020.1608","DOIUrl":"https://doi.org/10.1684/hma.2020.1608","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":"91 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67566483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum 勘误表
Q4 HEMATOLOGY Pub Date : 2020-10-01 DOI: 10.1684/hma.2020.1596
{"title":"Erratum","authors":"","doi":"10.1684/hma.2020.1596","DOIUrl":"https://doi.org/10.1684/hma.2020.1596","url":null,"abstract":"","PeriodicalId":42476,"journal":{"name":"Hematologie","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41815272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Hematologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1